Dosing Guidlines for Adults

Drug Detail for Adult Drugs


Rifabutin

Antimicrobial Agents

Antimycobacterial Antibiotics


General Toxicity Notes
Excreted Unchanged %
5-10
Half-Life (NormalESRD) hours
16-69/Unchanged
Plasma Protein Binding %
71-89
Volume of Distribution L/kg
8.2-9.3
Dose for Normal Renal Function
300 mg q24h
Second Dose
Adjustment for Renal Failure Method
Adjustment for Renal Failure GFR, mL/min >50 [Recommended Level]
100%[A]
Adjustment for Renal Failure GFR, mL/min 10-50 [Recommended Level]
100%[A]
Adjustment for Renal Failure GFR, mL/min <10 [Recommended Level]
100%[A]
Supplement for Dialysis [Recommendation Level]: IHD
IHD: None
Supplement for Dialysis [Recommendation Level]: PD
PD: None
Supplement for Dialysis [Recommendation Level]: CRRT
CRRT: 100%, [B]
References
Bassilios N, Launay-Vacher V, Hamani AA, Masias L, Peytavin G, Fau JB, et al. Pharmacokinetics and dosage adjustment of rifabutin in a haemodialysis patient [Letter]. Nephrol Dial Transplant. 2002; 17: 531-2. [PMID: 11865118] / Narang PK, Schoenfelder J, Bianchine JR. Impact of altered rifabutin disposition in renal disease on its safety in AIDS patients. AIDS. 1992; 6(Suppl 1): 90. [PMID unavailable] / Skinner MH, Hsieh M, Torseth J, Pauloin D, Bhatia G, Harkonen S, et al. Pharmacokinetics of rifabutin. Antimicrob Agents Chemother. 1989; 33: 1237-41. [PMID: 2552902]
Toxicity Notes